Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.

Interventional arm participants will receive Selenium as Selenious Acid infusion plus the standard of care therapy.

Active comparator arm participants will receive the standard of care therapy plus a Saline-based placebo.